漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.

Slides:



Advertisements
Similar presentations
“My movement was that of a drunk person. And that’s why I got fired” –Patient DC Amyotrophic Lateral Sclerosis.
Advertisements

Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (Lou Gehrig’s Disease)
Motor neuron disease What are motor neuron diseases? Who is at risk? What are the causes motor neuron diseases? How are they classified? What are the symptoms.
Diagnosis of motor neuron disease Pille Taba, Karin Rallmann University of Tartu VI Nordic ALS Alliance Meeting Aug 21, 2010 Haapsalu, Estonia.
Oddities – unusual non-motor symptoms in 3 ALS patients Authors: Muhammad Khan, MD, Rajan Patel, MD, Katalin Scherer, MD(Associate Professor of Neurology,
ALS By Arjun Puri and Navdeep Saini. Intro Amyotrophic Lateral Sclerosis Neurodegenerative disease Incurable and fatal Can affect anyone Life expectancy.
1 Chapter 14: Motor System Chris Rorden University of South Carolina Norman J. Arnold School of Public Health Department of Communication Sciences and.
Zinc-deficient SOD in ALS Emily Clark Dr. Joe Beckman Department of Biochemistry/Biophysics.
Amyotrophic Lateral Sclerosis (ALS)
ALS Kate Crain. Amyotrophic Lateral Sclerosis Lou Gehrig Disease Charcot’s Syndrome.
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
4 patients falling over. Mrs April Aged 62 Complains of tripping up when she walks on uneven surfaces Falls over and comes to hospital PMH COPD Vegan.
Neuromuscular disorders
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
Cellular Degeneration and Ageing Susan Rutherford and Sarah Christie.
AMYOTROPIC LATERAL SCLEROSIS. Commonly known as Lou Gehrig’s disease Combination of Upper Motor Neuron and Lower Motor Neuron disorder Degeneration and.
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
PATRICK CASEY FALL 2007 PARAMEDIC CLASS Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis and Superoxide Dimutase 1 (SOD1) Iasson Yi CHEM 4700.
Health Presentation Amyotrophic Lateral Sclerosis Zhenette Stevens.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Motor tracts Fern White Harvey Davies Questions:
Anterior Horn Cell Disorders Shekhar J.Lamdhade Shekhar J.Lamdhade Consultant Neurologist Consultant Neurologist Al Amiri Hospital Al Amiri Hospital.
Degenerative Myelopathy Benelli’s Story by Lauren Meadows.
Motor neuron disease Dr.Shamekh M. El-Shamy.
Amyotrophic Lateral Sclerosis (ALS)
BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Amyotrophic Lateral Sclerosis. Motor Neuron Disease Terminology Lower motor neuron Upper motor neuron Progressive Muscular Atrophy Amyotrophic Lateral.
A.L.S. A MYOTROPHIC L ATERAL S CLEROSIS. A.L.S. F ACTS.
47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
09f CLINICAL APPLICATIONS OF YOUR KNOWLEDGE OF THE MOTOR SYSTEMS.
Amyotrophic Lateral Sclerosis (ALS)
1 SPINAL CORD III Major Pathways of the Spinal Cord - Motor C.R. Houser.
Amyotrophic Lateral Sclerosis (ALS)
ALS Samuel Awad & Osama Jamali. Introduction ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds.
Teaching NeuroImages A 54-year-old man with progressive muscle weakness, hand tremor, tongue and perioral fasciculation Neurology Resident and Fellow Section.
ALS and Neuromuscular Diseases in Latvia Viktorija Ķēniņa M.D., Ph.D Neuroimmunologist at P. Stradins Clinical University Hospital.
Amyotrophic lateral sclerosis
The organization of the nervous system. Structure of the human cerebral cortex.
Under the supervision of miklós jászberényi
Amyotrophic Lateral Sclerosis
Stephen Hawking. Biography Stephen William Hawking was born on 8 January In Oxford, England. Stephen then went on to Cambridge to do research in.
Motor neuron disease.
Amyotrophic Lateral Sclerosis Online Database (ALSOD) Presenter : Olubunmi Abel.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
Approach to the Patient with Weakness. What are clinical features that might lead you to believe that weakness is peripheral? Why is it important to localize.
ZOO405 by Rania Baleela is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported LicenseRania BaleelaCreative Commons Attribution-
Motor Pathways Dr Ayman G. Abu-Tabanja.
Frontotemporal Lobar Degeneration:
Alzheimer Disease (Senile Dementia) Characterized by progressive memory loss, is increasingly common in developed countries as populations include more.
MOTOR NEURON DISEASE. Definition  Motor Neuron Diseases  group of diseases which include progressive degeneration and loss of motor neurons with or.
Diagnosing MND: what I say to patients and their families
Amyotrophic Lateral Sclerosis (ALS)
Ligament- A short band of tough,
Amyotrophic Lateral Sclerosis (ALS)
A potential therapy for ALS
Amyotrophic Lateral Sclerosis
What does this protein make up or do? amyotrophic lateral sclerosis
Long Term Effects of Concussions
Assessing the role of the ALS-associated gene NEK1 in zebrafish motor neuron development Amy Stark.
Respiratory Management in MND
2/15/2019 Shadab Salehpour.
Figure 1 Clinical aspects of LGMD subtypes
Respiratory Management in MND
Nervous System Disorders and Homeostatic Imbalances
By Ivy Stites and Keya Patel
Presentation transcript:

漸凍症 amyotrophic lateral sclerosis

Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993)

ALS: Epidemiology ALS is the most common form of motor neuron disease. Sporadic forms (unknown cause) account for about percent of ALS cases. Familial forms (AD inherited disease) make up approximately 5-10 percent. Slight male predominance for sporadic ALS.

ALS: Epidemiology The incidence of ALS increases with each decade, especially after age 40 years. Peak age of onset is 50-70’s. The only established risk factors for ALS are age and family history. Increased risk for developing ALS has been suggested for laborers engaged in agricultural work, factory work, heavy manual labor, exposure to welding or soldering, and work in the plastics industry.

ALS: Clinical Features The clinical hallmark of ALS is the combination of upper motor neuron and lower motor neuron signs. UMN signs include hyperreflexia, spasticity, extensor plantar response (up going toes), and positive jaw jerk. LMN signs include weakness, muscle atrophy, cramps and fasciculations.

causing progressive muscular atrophy loss of motor neurons in the spinal cord, brainstem and motor cortex patients die due to respiratory failure caused by bronchial muscular dystrophy in 3-5 years lose the ability to initiate and control all voluntary movement (John M et al. PNAS 2010) 8

ALS: Clinical Features The loss of motor neurons results in the primary clinical symptoms and signs ALS. These may produce impairment affecting limb, bulbar, axial and respiratory function. Differences in site of onset, pattern and speed of spread, and the degree of upper motor neuron (UMN) and/or lower motor neuron (LMN) dysfunction produce a disorder that is remarkably variable between individuals.

 neuroinflammation  glutamate excitotoxicity  altered cytoskeleton proteins  impaired axoplasmic transport  oxidative stress Origin of ALS (Bruijn LI et al Annu Rev Neurosci) (Al-Chalabi, A. and P.N. Leigh 2000 Curr Opin Neurol) (Conwit, R.A J Neurol Sci) 10

 glutamate excitotoxicity NMDA receptor D-serine Motor neuron death (apoptosis) overdosage (John M et al. PNAS 2010) glutamate 11

G72 D-serine D-serine pyruvate D-amino acid oxidase (DAO) NMDA receptor High D-serine excitotoxicitymotor neuron death amyotrophic lateral sclerosis 12

 oxidative stress ALS sporadic ALS 90~95% familial ALS 5~10% mutations in the gene encoding Cu/Zn superoixde dismutase 1 (SOD1) 20% (Rosen DR et al. Nature 1993) 13

NMDA receptor activity 14 (Sacchi et al. JBC 2008)